The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1944-446X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection ; volume:36 ; number:1 ; day:13 ; month:1 ; year:2017 ; pages:1-9 ; date:12.2017
Chinese journal of cancer ; 36, Heft 1 (13.1.2017), 1-9, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Kim, Young Saing
- Contributor
-
Jeong, Chi-Young
Song, Haa-Na
Kim, Tae Hyo
Kim, Hong Jun
Lee, Young-Joon
Hong, Soon Chan
SpringerLink (Online service)
- DOI
-
10.1186/s40880-017-0182-y
- URN
-
urn:nbn:de:1111-2017021113411
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kim, Young Saing
- Jeong, Chi-Young
- Song, Haa-Na
- Kim, Tae Hyo
- Kim, Hong Jun
- Lee, Young-Joon
- Hong, Soon Chan
- SpringerLink (Online service)
Other Objects (12)
Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment
Biliary tract radiology
Isolated brachioradialis metastasis of gastric adenocarcinoma after R0 resection
Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer
Imaging of Benign Biliary Tract Disease
Biliary Tract Obstruction by Unusual Parasites
Biliary Tract Obstruction Due to Sarcoidosis
Correction to: Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
R0 resection and reconstruction for a large, rapidly progressive chest wall sarcoma
Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment
Biliary tract radiology
Isolated brachioradialis metastasis of gastric adenocarcinoma after R0 resection
Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer
Imaging of Benign Biliary Tract Disease
Biliary Tract Obstruction by Unusual Parasites
Biliary Tract Obstruction Due to Sarcoidosis
Correction to: Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
R0 resection and reconstruction for a large, rapidly progressive chest wall sarcoma
Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment
Biliary tract radiology
Isolated brachioradialis metastasis of gastric adenocarcinoma after R0 resection
Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer
Imaging of Benign Biliary Tract Disease
Biliary Tract Obstruction by Unusual Parasites
Biliary Tract Obstruction Due to Sarcoidosis
Correction to: Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients